Use of Tocilizumab in patients with stable chronic liver disease and severe COVID-19 for prevention of decompensated cirrhosis, a prospective, open-label, randomized controlled trial

Renteria, L. A. R.; Jaramillo-Ramirez, H.; Calderon-Mendieta, F.; Camacho-Escobedo, J.; Avendano-Reyes, J. M.; Lopez-Rubio, D. L.; Araiza, A. S.; Reyes-Higuera, G. E.; Soto-Gonzalez, D. R.; Arzola-Renteria, E. J.

Renteria, L. A. R.; Jaramillo-Ramirez, H.; Calderon-Mendieta, F.; Camacho-Escobedo, J.; Avendano-Reyes, J. M.; Lopez-Rubio, D. L.; Araiza, A. S.; Reyes-Higuera, G. E.; Soto-Gonzalez, D. R.; Arzola-Renteria, E. J..

Journal of Hepatology ; 77:S356-S356, 2022.

Article in English | Web of Science | ID: covidwho-1981039

Keywords

Gastroenterology & Hepatology

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Journal of Hepatology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML